ARCHIVES

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

This article is from The Cancer Letter archive.

Vol. 40 No. 25 | June 20, 2014

Download PDF Visit The Full Archive

Related Articles

Selumetinib Displays Positive Results, 60% with Stable Disease

April 29, 2011

Women PIs Score Highest In RFA To Encourage Early Breast Cancer Detection

May 1, 1987

Joe Gray Moves To OHSU Knight Cancer Institute

January 21, 2011

Cancer Policy Board urges distinct care for cancer survivors.

November 11, 2005

IOM Reports Says HIPPA Privacy Rule Hinders Research, Doesn’t Protect Patient Privacy

February 6, 2009

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

December 31, 2010